Koyfin Home > Directory > Health Care > Acadia Pharmaceutica > Cash and Short-Term Investments

Acadia Pharmaceutica Cash and Short-Term Investments Chart (ACAD)

Acadia Pharmaceutica annual/quarterly Cash and Short-Term Investments from 2010 to 2020.
  • Acadia Pharmaceutica Cash and Short-Term Investments for the quarter ending June 06, 2020 was $659m a -3.84% decrease of -25m year over year
  • Acadia Pharmaceutica Cash and Short-Term Investments for the last 12 months ending June 06, 2020 was $659m a -3.84% decrease of -25m year over year
  • Acadia Pharmaceutica Annual Cash and Short-Term Investments for 2019 was $697m a 32.10% increase of 224m from 2018
  • Acadia Pharmaceutica Annual Cash and Short-Term Investments for 2018 was $474m a 27.91% increase of 132m from 2017
  • Acadia Pharmaceutica Annual Cash and Short-Term Investments for 2017 was $341m a -54.99% decrease of -188m from 2016
Other Balance Sheet Metrics:
  • Acadia Pharmaceutica Total Assets for the quarter ending September 09, 2018 was $266m a -44.30% decrease of -118m year over year
  • Acadia Pharmaceutica Other Liabilities for the quarter ending December 12, 2018 was $2m a 49.81% increase of 1m year over year
  • Acadia Pharmaceutica Total Equity for the quarter ending September 09, 2018 was $223m a -50.06% decrease of -112m year over year
View Chart On Koyfin

Quarterly ACAD Cash and Short-Term Investments Data

06/2020$659m
03/2020$651m
12/2019$697m
09/2019$684m
06/2019$382m
03/2019$414m
12/2018$474m
09/2018$214m
06/2018$257m
03/2018$298m

Annual ACAD Cash and Short-Term Investments Data

2019$697m
2018$474m
2017$341m
2016$529m
2015$215m
2014$322m
2013$186m
2012$108m
2011$31m
2010$37m